Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	200-300
Total Project Funding per Partner:	300-400
Total Number of Projects:	200-300
2019
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	100-200
2018
Criterium:	Position:
Overall Score:	300-400
Total Project Funding per Partner:	700-800
Total Number of Projects:	700-800
Networking Rank (Reputation):	100-200
2017
Criterium:	Position:
Overall Score:	300-400
Total Project Funding per Partner:	300-400
Total Number of Projects:	400-500
Networking Rank (Reputation):	300-400
2016
Criterium:	Position:
Overall Score:	200-300
Total Project Funding per Partner:	100-200
Total Number of Projects:	200-300
Networking Rank (Reputation):	500-600

Ranking timeline:

Project Participation Performance(2016-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 91
As coordinator: 15
As participant: 68
Sole participant: 8
Coordinator / Participant Ratio: 0.22^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2023	4.781.099	10.201.999	4.267.394	2	4
2022	203.464	43.671.957	3.517.728	1	8
2021	7.832.226	67.809.575	7.484.613	2	13
2020	6.619.072	49.825.857	5.810.830	6	9
2019	22.176.012	102.675.617	13.460.793	4	14
2018	6.527.723	4.250.370	2.055.111	2	2
2017	5.407.488	50.188.027	2.853.901	2	4
2016	18.344.566	62.382.604	10.689.862	4	14

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	13
STICHTING VU	12
JANSSEN PHARMACEUTICA NV	11
KAROLINSKA INSTITUTE	11
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	10
KATHOLIEKE UNIVERSITEIT LEUVEN	10
UNIVERSITEIT GENT	9
UNIVERSITY OF OSLO	9
ACADEMISCH ZIEKENHUIS GRONINGEN	8
NOVARTIS PHARMA	8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	8
UNIVERSITY COLLEGE LONDON	8
UNIVERSITY OF CAMBRIDGE	8
CHARITE UNIVERSITAETSMEDIZIN BERLIN	7
REGION HOVEDSTADEN	7
UNIVERSITY OF HELSINKI	7
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	6
KING'S COLLEGE LONDON	6
PFIZER LIMITED	6
STICHTING LYGATURE	6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	6
UNIVERSITE DE GENEVE	6
VRIJE UNIVERSITEIT BRUSSEL	6
ALZHEIMER EUROPE	5
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM	5
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	5
EUREC OFFICE GUG	5
EUROPEAN CANCER PATIENT COALITION	5
EUROPEAN MOLECULAR BIOLOGY LABORATORY	5
F HOFFMANNLA ROCHE	5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	5
MEDIZINISCHE UNIVERSITAET WIEN	5
TAKEDA DEVELOPMENT CENTRE EUROPE	5
TAKEDA PHARMACEUTICALS INTERNATIONAL	5
TARTU ULIKOOL	5
THE UNIVERSITY OF NOTTINGHAM	5
UNIVERSITY OF COPENHAGEN	5
UNIVERSITY OF NEWCASTLE UPON TYNE	5
UPPSALA UNIVERSITET	5
VIB VZW	5
VRIJE UNIVERSITEIT AMSTERDAM VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJS	5
ACADEMIC MEDICAL CENTRE AMSTERDAM	4
BAYER	4
CARL ZEISS	4
CENTRE DE REGULACIO GENOMICA	4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	4
CONSIGLIO NAZIONALE DELLE RICERCHE	4
ELI LILLY AND COMPANY LIMITED	4
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS	4
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE	4
MASARYKOVA UNIVERZITA	4
OSPEDALE PEDIATRICO BAMBINO GESU	4
STICHTING RADBOUD UNIVERSITEIT	4
SVEUCILISTE U SPLITU MEDICINSKI FAKULTET	4
UNIVERSITAETSKLINIKUM FREIBURG	4
UNIVERSITE DU LUXEMBOURG	4
UNIVERSITEIT MAASTRICHT	4
UNIVERSITY OF BOLOGNA	4
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	3
CELGENE MANAGEMENT SARL	3
CENTRO DE INVESTIGACION BIOMEDICA EN RED	3
COMMISSARIAT A L'ENERGIE ATOMIQUE	3
EATRIS ERIC	3
EUROPEAN HEMATOLOGY ASSOCIATION	3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA	3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON	3
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA	3
GMV SOLUCIONES GLOBALES INTERNET SAU	3
GOETEBORGS UNIVERSITET	3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	3
H LUNDBECK AS	3
LEIDEN UNIVERSITY	3
LEIDS UNIVERSITAIR MEDISCH CENTRUM	3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	3
NATIONAL TECHNICAL UNIVERSITY OF ATHENS	3
NOVO NORDISK	3
OSLO UNIVERSITETSSYKEHUS HF	3
PROVINCIA LOMBARDO VENETA ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO FATEBENEFRATELLI	3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG	3
SANOFIAVENTIS	3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM	3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	3
TERVEYDEN JA HYVINVOINNIN LAITOS	3
THE UNIVERSITY OF EDINBURGH	3
THE UNIVERSITY OF MANCHESTER	3
UNIVERSIDAD AUTONOMA DE MADRID	3
UNIVERSIDAD DE NAVARRA	3
UNIVERSITA CATTOLICA DEL SACRO CUORE	3
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA	3
UNIVERSITA DEGLI STUDI DI TORINO	3
UNIVERSITAET ULM	3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT	3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ	3
UNIVERSITATSKLINIKUM BONN	3
UNIVERSITEIT UTRECHT	3
UNIVERSITY OF AARHUS	3
UNIVERZA V LJUBLJANI	3
UNIWERSYTET JAGIELLONSKI	3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER	3
ABBVIE INC	2

Constancy:

Total number of partners: 1261
Partner loyalty:
Frequent Partner: (> 2 projects): 469
Rare Partner: 792
Frequent / Rare Partner Ratio: 0.59

Project overview:

Start date	Project	acronym	role	funding	partners
2023-03-01	Mending sex differences: Unravelling the female predominance in pulmonary hypertension	FEMALE-PH	coordinator	1.499.999	1
2023-01-01	A Youth-centred Preventive Action Approach towards co-created implementation of socially and Physically activating Environmental interventions	YoPAAPE	coordinator	3.281.100	10
2023-01-01	Cohesin and its regulators: from chromosome dynamics and nuclear architecture to human diseases	CohesiNet	participant	2.649.823	20
2023-01-01	TIER2: ENHANCING TRUST, INTEGRITY AND EFFICIENCY IN RESEARCH THROUGH NEXT-LEVEL REPRODUCIBILITY IMPACT PATHWAYS	TIER2	participant	1.791.500	10
2023-01-01	Catalysation of institutional transformations of Higher Education Institutions through the adoption of acceleration services	CATALISI	participant	3.219.156	11
2023-01-01	Beyond Bad Apples: Towards a Behavioral and Evidence-Based Approach to Promote Research Ethics and Research Integrity in Europe	BEYOND	participant	2.541.520	14
2022-10-01	improving Research Ethics Expertise and Competences to Ensure Reliability and Trust in Science	iRECS	participant	3.794.374	18
2022-09-01	Moral residue - epistemological ramifications, ethical implications and didactic opportunities	MORE	participant	2.455.263	4
2022-09-01	Implementation and evaluation of a Navigation Intervention for People with Cancer in Old Age and their Family Caregivers: an international pragmatic randomized controlled trial	EU NAVIGATE	participant	5.993.222	12
2022-09-01	A PeRsOnalized Prevention roadmap for the future HEalThcare	PROPHET	participant	2.812.437	20
2022-09-01	Pro-active Pandemic Crisis Ethics and Integrity Framework	PREPARED	participant	4.201.759	16
2022-08-01	INnoVAtive Solution for Imaging of Infiltrating mONocytes	INVASIION	coordinator	203.464	1
2022-07-01	eBRAIN-Health - Actionable Multilevel Health Data	eBRAIN-Health	participant	12.436.805	20
2022-06-01	RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY	CANCERNA	participant	5.999.381	13
2022-05-01	VALIDATING AI IN CLASSIFYING CANCER IN REAL-TIME SURGERY	CLASSICA	participant	5.978.716	11
2021-11-01	European platform for neurodegenerative disorders	EPND	participant	9.680.000	29
2021-10-01	Beyond COVID	BY-COVID	participant	12.000.000	53
2021-07-01	PI3K/PTEN-related monogenic disease to understand cancer	PIPgen	participant	4.099.075	11
2021-06-01	Psychiatric Ratings using Intermediate Stratified Markers 2	PRISM 2	participant	3.980.906	18
2021-06-01	Individualized CARE for Older Persons with Complex Chronic Conditions at home and in nursing homes	I-CARE4OLD	coordinator	5.832.536	14
2021-04-01	POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment	POLYRISK	participant	5.991.078	15
2021-04-01	Non-coding RNA and Intercellular Communication in Cardiac Ageing	NICCA	coordinator	1.999.690	1
2021-04-01	Tau Pathology in Alzheimer’s disease: Spreading and Resilience	TAU-NOW	participant	1.500.000	2
2021-03-01	A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis	GLYTUNES	participant	3.744.224	11
2021-03-01	Training Network for Optimizing Adoptive T cell Therapy of Cancer	T-OP	participant	4.100.959	12
2021-03-01	Anti-Cancer Light-Controllable Antibody-Peptide Conjugates	ALISE	participant	745.200	7
2021-02-01	Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine	TIGER	participant	6.900.000	8
2021-01-01	Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy	T2EVOLVE	participant	8.728.185	29
2021-01-01	Evidence-based co-creation methodology for bridging the implementation gap between knowledge and action in health promotion.	Health CASCADE	participant	4.058.109	7
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2020-12-01	Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic	RESPOND	participant	6.172.028	17
2020-11-01	Drug discovery screening using human neurons	HumanNeuronScreen	coordinator	150.000	1
2020-10-01	Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration	SkinTERM	participant	3.192.736	9
2020-10-01	HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS	HARMONY PLUS	participant	6.715.625	41
2020-07-01	Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).	Impentri	participant	3.662.963	5
2020-06-01	Chimeric antigen receptor (CAR) T-cell therapy against solid tumors by targeting the vasculature	AngioCAR	coordinator	175.572	1
2020-06-01	Beyond 1M Genomes	B1MG	participant	4.000.000	37
2020-05-01	Molecular Imaging of Microglia	MIM	coordinator	175.572	1
2020-04-01	Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity	EDUC8	participant	2.100.702	9
2020-02-01	Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells	UNPACK PD-L1	coordinator	175.572	1
2020-01-01	RISK-BASED SCREENING FOR CERVICAL CANCER	RISCC	coordinator	5.792.355	11
2020-01-01	EXposome Powered tools for healthy living in urbAN SEttings	EXPANSE	participant	11.993.907	21
2020-01-01	Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity	EarlyCause	participant	5.997.381	14
2020-01-01	Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research	MATCH	coordinator	150.000	1
2020-01-01	A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities	TO_AITION	participant	5.990.515	14
2019-11-01	Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis	MIRIADE	coordinator	4.015.376	11
2019-10-01	Exploitation of the SECRETory pathway for cancer therapy to address European research	SECRET	participant	3.915.872	12
2019-10-01	Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies	Immune-Image	coordinator	15.000.000	23
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-06-01	Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis	Host-TB	coordinator	2.160.926	2

overview shows latest 50 from 91 projects (2016-01-01 - 2024-12-31)
A full list of projects can be found here:

STICHTING VUMC -